Mouse Anti-DPAGT1 Recombinant Antibody (1G1) (V2LY-0425-LY809)

Mitachi, K., Mingle, D., Effah, W., Sánchez-Ruiz, A., Hevener, K. E., Narayanan, R., ... & Kurosu, M. (2022). Concise Synthesis of Tunicamycin V and Discovery of a Cytostatic DPAGT1 Inhibitor. Angewandte Chemie.

Liu, Z., Yang, S., Chen, X., Dong, S., Zhou, S., & Xu, S. (2021). LncRNA LINC00467 acted as an oncogene in esophageal squamous cell carcinoma by accelerating cell proliferation and preventing cell apoptosis via the miR‐485‐5p/DPAGT1 axis. Journal of Gastroenterology and Hepatology, 36(3), 721-730.

Mitachi, K., Kansal, R. G., Hevener, K. E., Gillman, C. D., Hussain, S. M., Yun, H. G., ... & Kurosu, M. (2020). DPAGT1 inhibitors of capuramycin analogues and their antimigratory activities of solid tumors. Journal of medicinal chemistry, 63(19), 10855-10878.

Li, H., You, L., Tian, Y., Guo, J., Fang, X., Zhou, C., ... & Su, Y. Q. (2020). DPAGT1‐Mediated Protein N‐Glycosylation Is Indispensable for Oocyte and Follicle Development in Mice. Advanced Science, 7(14), 2000531.

Mitachi, K., Kurosu, S. M., Eslamimehr, S., Lemieux, M. R., Ishizaki, Y., Clemons Jr, W. M., & Kurosu, M. (2019). Semisynthesis of an anticancer DPAGT1 inhibitor from a muraymycin biosynthetic intermediate. Organic letters, 21(4), 876-879.

Li, R., Xu, T., Wang, H., Wu, N., Liu, F., Jia, X., ... & Gao, H. (2019). Dysregulation of the miR-325–3p/DPAGT1 axis supports HBV-positive HCC chemoresistance. Biochemical and biophysical research communications, 519(2), 358-365.

Mitachi, K., Kurosu, S. M., Gillman, C. D., Yun, H. G., Clemons Jr, W. M., & Kurosu, M. (2019). A practical synthesis of a novel DPAGT1 inhibitor, aminouridyl phenoxypiperidinbenzyl butanamide (APPB) for in vivo studies. MethodsX, 6, 2305-2321.

Dong, Y. Y., Wang, H., Pike, A. C., Cochrane, S. A., Hamedzadeh, S., Wyszyński, F. J., ... & Carpenter, E. P. (2018). Structures of DPAGT1 explain glycosylation disease mechanisms and advance TB antibiotic design. Cell, 175(4), 1045-1058.

Ng, B. G., Underhill, H. R., Palm, L., Bengtson, P., Rozet, J. M., Gerber, S., ... & University of Washington Center for Mendelian Genomics. (2018). DPAGT1 deficiency with encephalopathy (DPAGT1-CDG): clinical and genetic description of 11 new patients. In JIMD Reports, Volume 44 (pp. 85-92). Springer, Berlin, Heidelberg.

Yuste-Checa, P., Vega, A. I., Martín-Higueras, C., Medrano, C., Gámez, A., Desviat, L. R., ... & Pérez, B. (2017). DPAGT1-CDG: Functional analysis of disease-causing pathogenic mutations and role of endoplasmic reticulum stress. PLoS One, 12(6), e0179456.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme-Linked Immunospot (ELISpot)
Proteogenomics
Other Protocols